SHR7280, an oral gonadotropin-releasing hormone antagonist, for the prevention of premature luteinizing hormone surge in controlled ovarian hyperstimulation: a dose-finding, phase 2 trial
Authors
Jie Qiao (ORCID: https://orcid.org/0000-0003-2126-1376)
Hongbin Chi (ORCID: https://orcid.org/0009-0000-9834-6250)
SHR7280, an oral gonadotropin-releasing hormone antagonist, for the prevention of premature luteinizing hormone surge in controlled ovarian hyperstimulation: a dose-finding, phase 2 trial
Jie Qiao, Hongbin Chi, Feiyang Diao, Jichun Tan et al.
Journal
Human Reproduction
Topics
Ovarian function and disorders
article
SHR7280, an oral gonadotropin-releasing hormone antagonist, for the prevention of premature luteinizing hormone surge in controlled ovarian hyperstimulation: a dose-finding, phase 2 trial
Jie Qiao, Hongbin Chi, Feiyang Diao, Jichun Tan, Lei Jin, Yanping Li, Yichun Guan, Xueru Song, Kai Shen, Zhi Li, Hong Chen, Xiaohong Wang, Ying Song, Yunxia Cao, Qianhong Ma, Chang Shu, Xiaoyan Liang, Yuqi Sun
article en
Abstract
No abstract available for this paper.
Publication Tag
Human ReproductionVol. 40(7)
Institutions
Central South University (CN), Sun Yat-sen University (CN), Anhui Medical University (CN), Peking University (CN), Sichuan University (CN), Tianjin Medical University General Hospital (CN), West China Second University Hospital of Sichuan University (CN), Sixth Affiliated Hospital of Sun Yat-sen University (CN), Military University (RU), National Clinical Research (US), First Affiliated Hospital of Anhui Medical University (CN), Peking University Third Hospital (CN), Third Affiliated Hospital of Zhengzhou University (CN), Jiangsu Hengrui Medicine (China) (CN), Tang Du Hospital (CN), Xiangya Hospital Central South University (CN), Tongji Hospital (CN), Beijing Obstetrics and Gynecology Hospital (CN), Huazhong University of Science and Technology (CN), Nanjing Medical University (CN), China Medical University (CN)